|
1
|
Jablonska S: The concept of scleroderma
and its classification. In: Scleroderma and Pseudoscleroderma.
Jablonska S (ed). Polish Medical Publishers, Warsaw, pp3-10,
1975.
|
|
2
|
Provost TT, Greenberg AS and Falanga V:
Localized cutaneous sclerosis. In: Cutaneous Manifestations of
Rheumatic Diseases. 1st edition. Sontheimer RD and Provost TT
(eds). Williams & Wilkins, Baltimore, MD, p125, 1996.
|
|
3
|
Laxer RM and Zulian F: Localized
scleroderma. Curr Opin Rheumatol. 18:606–613. 2006.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Jacobe H: Pathogenesis, clinical
manifestations, and diagnosis of morphea (localized scleroderma) in
adults - UpToDate. https://www.uptodate.com/contents/pathogenesis-clinical-manifestations-and-diagnosis-of-morphea-localized-scleroderma-in-adults.
Accessed May 31, 2019.
|
|
5
|
Jacobe H: Treatment of morphea (localized
scleroderma) in adults - UpToDate. https://www.uptodate.com/contents/treatment-of-morphea-localized-scleroderma-in-adults.
Accessed April 16, 2018.
|
|
6
|
Zulian F: Localized scleroderma in
childhood - UpToDate. https://www.uptodate.com/contents/localized-scleroderma-in-childhood.
Accessed April 3, 2019.
|
|
7
|
Aberer E, Kollegger H, Kristoferitsch W
and Stanek G: Neuroborreliosis in morphea and lichen sclerosus et
atrophicus. J Am Acad Dermatol. 19:820–825. 1988.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Aberer E, Stanek G, Ertl M and Neumann R:
Evidence for spirochetal origin of circumscribed scleroderma
(morphea). Acta Derm Venereol. 67:225–231. 1987.PubMed/NCBI
|
|
9
|
Schempp C, Bocklage H, Lange R, Kölmel HW,
Orfanos CE and Gollnick H: Further evidence for Borrelia
burgdorferi infection in morphea and lichen sclerosus et
atrophicus confirmed by DNA amplification. J Invest Dermatol.
100:717–720. 1993.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Wienecke R, Schlüpen EM, Zöchling N,
Neubert U, Meurer M and Volkenandt M: No evidence for Borrelia
burgdorferi-specific DNA in lesions of localized scleroderma. J
Invest Dermatol. 104:23–26. 1995.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Weide B, Walz T and Garbe C: Is morphoea
caused by Borrelia burgdorferi? A review. Br J Dermatol.
142:636–644. 2000.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Aberer E, Neumann R and Stanek G: Is
localised scleroderma a Borrelia infection? Lancet.
2(278)1985.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Cunningham BB, Landells ID, Langman C,
Sailer DE and Paller AS: Topical calcipotriene for morphea/linear
scleroderma. J Am Acad Dermatol. 39:211–215. 1998.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Kreuter A, Gambichler T, Breuckmann F,
Rotterdam S, Freitag M, Stuecker M, Hoffmann K and Altmeyer P:
Pulsed high-dose corticosteroids combined with low-dose
methotrexate in severe localized scleroderma. Arch Dermatol.
141:847–852. 2005.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Vilela FA, Carneiro S and Ramos-e-Silva M:
Treatment of morphea or localized scleroderma: Review of the
literature. J Drugs Dermatol. 9:1213–1219. 2010.PubMed/NCBI
|
|
16
|
Constantin MM, Cristea CM, Taranu T, Bucur
S, Constantin T, Dinu A, Jinga M and Nita IE: Biosimilars in
dermatology: The wind of change. Exp Ther Med. 18:911–915.
2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Raducan A, Bucur S, Caruntu C, Constantin
T, Nita IE, Manolache N and Constantin MM: Therapeutic management
with biological anti-TNF-α agent in severe psoriasis associated
with chronic hepatitis B: A case report. Exp Ther Med. 18:895–899.
2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Diab M, Coloe JR, Magro C and Bechtel MA:
Treatment of recalcitrant generalized morphea with infliximab. Arch
Dermatol. 146:601–604. 2010.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Dumitrascu MC, Stanescu AMA, Bejan C,
Sandru F, Toader DO, Radavoi GD, Cotirlet A, Judea PCT and Diaconu
CC: Obesity and its implications on stress urinary incontinence.
Rev Chim (Bucharest). 70:3660–3662. 2019.
|
|
20
|
Mertens JS, Seyger MM, Kievit W,
Hoppenreijs EP, Jansen TL, van de Kerkhof PC, Radstake TR and de
Jong EM: Disease recurrence in localized scleroderma: A
retrospective analysis of 344 patients with paediatric- or
adult-onset disease. Br J Dermatol. 172:722–728. 2015.PubMed/NCBI View Article : Google Scholar
|
